Could a simple ultrasound replace costly MRIs for fatty liver diagnosis?

NCT ID NCT07192159

Recruiting now Diagnosis Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new ultrasound technology called DeepUSFF to measure fat in the liver of people with metabolic fatty liver disease (MASLD). Researchers will compare the ultrasound results to MRI scans, which are the current gold standard. If the ultrasound works well, it could offer a quicker, cheaper, and more widely available way to diagnose and track this common liver condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Quantitative ultrasound (DeepUSFF) device
What this could lead to: If successful, this could provide a faster, cheaper, and more accessible way to diagnose and monitor fatty liver disease without needing an MRI.
What could go wrong: This is a small, early-stage study (62 people) focused on accuracy, not treatment. The technology may not prove reliable enough to replace MRI in all cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATIC STEATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fatty liver disease liver disorder metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATIC STEATOSIS LIVER DISEASE PARENCHYMAL METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Contacts and locations

Locations

Seoul National University Hospital
RECRUITING

Seoul, Seoul, 03080, South Korea
southwoods imaging (Northeastern Ohio Radiology Research and Education Fund )
RECRUITING

Boardman, Ohio, 44512, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.